Kaplan–Meier analysis revealed that, in GBM cases, patients with high S100A4 scores had poorer OS and PFS when compared to patients with low scores, but such associations were not observed with regard to NMIIA scores (Fig. 7A). The gene discussed is S100A4; the disease is glioblastoma.